IL-17A has been shown to stimulate the activation of HSCs and contribute to liver fibrosis by increasing the expression of pro-inflammatory cytokines, such as IL-6, IL-1β, and TNF-α, as well as pro-fibrotic factors like TGF-β and α-SMA. This evidence concerns the gene IL6 and Hepatic fibrosis.